Clinical Trial Update: A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients [Phase 2]

View source ↗

Summary

A Phase II trial of SB-480848 in dyslipidemic patients with atherosclerosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• SB-480848

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 2 | Status: COMPLETED | Results posted: 2018-01-12